SCHEMBL5038583

SCHEMBL5038583

NC(=O)CNC(=O)c1ccc(Cl)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.62
TSHR P16473 1/20 0.62
NFKB1 P19838 1/20 0.62
MAOB P27338 1/20 0.62
MAPT P10636 3/20 0.62
KDM4E B2RXH2 2/20 0.62
ALDH1A1 P00352 1/20 0.62
LMNA P02545 1/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
BLM P54132 1/20 0.61
PMP22 Q01453 1/20 0.61
MMP1 P03956 1/20 0.55
SLC6A9 P48067 1/20 0.51
SLC6A5 Q9Y345 1/20 0.51
GAA P10253 2/20 0.50
GPR139 Q6DWJ6 1/20 0.50
HIF1A Q16665 1/20 0.50
SLC22A6 Q4U2R8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Chlorohippuric Acid SCHEMBL4002486 0.82 KDM4E (0.67) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL6200322 0.82 MEN1 (0.62) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL1913984 0.82 KDM4E (0.72) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL11210009 0.82 MEN1 (0.60) CYP1A2TSHRNFKB1MAOBMAPT
4-Chlorohippuric Acid SCHEMBL11524882 0.82 KDM4E (0.67) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL3363697 0.82 CYP1A2 (0.63) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL11294257 0.81 CYP1A2 (0.69) CYP1A2TSHRNFKB1MAOBMAPT
4-Chlorohippuric Acid SCHEMBL11522704 0.81 MAPT (0.65) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL11004530 0.81 MEN1 (0.58) CYP1A2TSHRNFKB1MAOBMAPT
SCHEMBL95020 0.81 CA1 (0.50) CYP1A2TSHRNFKB1MAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104177348-A Antineoplastic compound N-(2-(4-chlorophenyl)-5-oxazolyl)-2-(1,3-dioxo-2-isoindolinyl)acetamide synthesis method KEJIE BIO SUZHOU PHARMACEUTICALS CO LTD 2014-12-03 CN disclosed
EP-1450796-B1 BENZOTHIAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
US-6596718-B1 A compound of formula I has a good affinity to the A2A receptor and is useful for the treatment of diseases mediated by this receptor. HOFFMANN-LA ROCHE INC. 2003-07-22 US disclosed
EP-0549600-A1 5-TRIFLUOROACYLAMINO-2-ARYL OXAZOLES PFIZER INC. (US) 1993-07-07 EP disclosed
WO-1992005163-A1 5-TRIFLUOROACYLAMINO-2-ARYL OXAZOLES PFIZER INC. (US) 1992-04-02 WO disclosed